Microarray analysis of cytokine activation of apoptosis pathways in the thyroid

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4844-4852

  Su, He Wang ^a   Van Antwerp, Mary ^a   Kuick, Rork ^b   Gauger, Paul G ^a   Doherty, Gerard M ^a   Yang, Yi Fan ^a   Baker Jr , James R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AQUAPORIN 9; CASPASE 10; CASPASE 3; CASPASE 7; CASPASE INHIBITOR; CHEMOKINE; CYTOKINE; DEATH RECEPTOR; ENDOTHELIN 1; EPHRIN A1; FAS ANTIGEN; GAMMA INTERFERON; GAP JUNCTION PROTEIN; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HEMATOPOIETIC CELL KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 7 RECEPTOR; KYNURENINASE; METALLOTHIONEIN I; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROPERDIN; PROSTAGLANDIN E SYNTHASE; RECEPTOR INTERACTING PROTEIN 2; RETINOIC ACID RECEPTOR; SERUM AMYLOID A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOIMMUNE THYROIDITIS; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; THYROID CELL; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASES; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1BETA; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; THYROID GLAND; TRANSCRIPTION, GENETIC;

EID: 34748919419     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0126     Document Type: Article

References (38)

1. Baker Jr JR 1999 Dying (apoptosing?) for a consensus on the Fas death pathway in the thyroid. J Clin Endocrinol Metab 84:2593-2595
2. Mezosi E, Wang SH, Utsugi S, Bajnok L, Bretz JD, Gauger PG, Thompson NW, Baker Jr JR 2005 Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells. Mol Endocrinol 19:804-811
3. Bretz, JD, Arscott PL, Myc A, Baker Jr JR 1999 Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J Biol Chem 274:25433-25438
4. Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, Baker Jr JR 2002 A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 168:2470-2474
5. Barnhart BC, Alappat EC, Peter ME 2003 The CD95 type I/type II model. Semin Immunol 15:185-193
6. Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schutze S, Peter ME, Chan AC 2006 The role of receptor internalization in CD95 signaling. EMBO J 25:1009-1023
7. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME 1999 Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274:22532-22538
8. Wang SH, Koenig RJ, Giordano TJ, Myc A, Thompson NW, Baker Jr JR 1999 1α,25-dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death. Endocrinology 140:1649-1656
9. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE 2001 MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem 276:16484-16490
10. Kreuz S, Siegmund D, Rumpf JJ, Samel D, Leverkus M, Janssen O, Hacker G, Dittrich-Breiholz O, Kracht M, Scheurich P, Wajant H 2004 NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 166:369-380
11. Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, Gauger P, Doherty G, Thompson NW, Hanash S, Koenig RJ, Nikiforov YE 2005 Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 24:6646-6656
12. Shedden K, Chen W, Kuick R, Ghosh D, Macdonald J, Cho KR, Giordano TJ, Gruber SB, Fearon ER, Taylor JM, Hanash S 2005 Comparison of seven methods for producing Affymetrix expression scores based on false discovery rates in disease profiling data. BMC Bioinformatics 6:26
13. Killinger Jr WA, Dorofi DB, Tinsley Jr EA, Keagy BA, Johnson Jr G 1992 Flow cytometric analysis of organ preservation-induced endothelial cell membrane damage. Ann Thorac Surg 53:472-476
14. Lee M, Chang I, Kim S 2004 Death effectors of β-cell apoptosis in type 1 diabetes. Mol Genet Metab 83:82-89
15. Stassi G, Di Liberto D, Todaro M, Zeuner A, Ricci-Vitiani L, Stoppacciaro A, Ruco L, Farina F, Zummo G, De Maria R 2000 Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nat Immunol 1:483-488
16. Curtin JF, Cotter TG 2003 Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 15:983-992
17. Kavurma MM, Khachigian LM 2003 Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 10:36-44
18. Chou JJ, Li H, Salvesen GS, Yuan J 1999 Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96:615-624
19. Harada H, Grant S 2003 Apoptosis regulators. Rev Clin Exp Hematol 7:117-138
20. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM 2001 Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282:1075-1079
21. Brune B, von Knethen A, Sandau KB 1999 Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 6:969-975
22. Kim PK, Zamora R, Petrosko P, Billiar TR 2001 The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 1:1421-1441
23. Stanford A, Chen Y, Zhang XR, Hoffman R, Zamora R, Ford HR 2001 Nitric oxide mediates dendritic cell apoptosis by downregulating inhibitors of apoptosis proteins and upregulating effector caspase activity. Surgery 130:326-332
24. Cui ZG, Kondo T, Matsumoto H 2006 Enhancement of apoptosis by nitric oxide released from α-phenyl-tert-butyl nitrone under hyperthermic conditions. J Cell Physiol 206:468-476
25. Yabuki M, Tsutsui K, Horton AA, Yoshioka T, Utsumi K 2000 Caspase activation and cytochrome c release during HL-60 cell apoptosis induced by a nitric oxide donor. Free Radic Res 32:507-514
26. Chae IH, Park KW, Kim HS, Oh BH 2004 Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim Acta 341:83-91
27. Millet A, Bettaieb A, Renaud F, Prevotat L, Hammann A, Solary E, Mignotte B, Jeannin JF 2002 Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. Gastroenterology 123:235-246
28. Sandau KB, Brune B 2000 Molecular actions of nitric oxide in mesangial cells. Histol Histopathol 15:1151-1158
29. Kuhn K, Shikhman AR, Lotz M 2003 Role of nitric oxide, reactive oxygen species, and p38 MAP kinase in the regulation of human chondrocyte apoptosis. J Cell Physiol 197:379-387
30. Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ, Morrison RS 2000 p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 150:335-347
31. Kao SJ, Lei HC, Kuo CT, Chang MS, Chen BC, Chang YC, Chiu WT, Lin CH 2005 Lipoteichoic acid induces nuclear factor-κB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology 115:366-374
32. N'Guessan PD, Schmeck B, Ayim A, Hocke AC, Brell B, Hammerschmidt S, Rosseau S, Suttorp N, Hippenstiel S 2005 Streptococcus pneumoniae R6x induced p38 MAPK and JNK-mediated caspase-dependent apoptosis in human endothelial cells. Thromb Haemost 94:295-303
33. Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, Oh TH, Markelonis GJ, Cho JW, Oh YJ 2004 Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 279:20451-20460
34. Pearl-Yafe M, Halperin D, Scheuerman O, Fabian I 2004 The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. Biochem Pharmacol 67:539-546
35. McCarthy JV, Ni J, Dixit VM 1998 RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J Biol Chem 273:16968-16975
36. Argast GM, Fausto N, Campbell JS 2005 Inhibition of RIP2/RIck/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK. Mol Cell Biochem 268:129-140
37. Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK 2005 Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-κB activation in muramyl dipeptide recognition. J Cell Biol 170:21-26
38. Eckelman BP, Salvesen GS 2006 The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 281:3254-3260